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Hemichannels (HCs) and gap junction channels (GJCs) formed by protein subunits
called connexins (Cxs) are major pathways for intercellular communication. While
HCs connect the intracellular compartment with the extracellular milieu, GJCs allow
the interchange of molecules between cytoplasm of two contacting cells. Under
physiological conditions, HCs are mostly closed, but they can open under certain stimuli
allowing the release of autocrine and paracrine molecules. Moreover, some pathological
conditions, like ischemia or other inflammation conditions, significantly increase HCs
activity. In addition, some mutations in Cx genes associated with human diseases, such
as deafness or cataracts, lead to the formation of more active HCs or “leaky HCs.” In
this article we will revise cellular and molecular mechanisms underlying the appearance
of leaky HCs, and the consequences of their expression in different cellular systems and
animal models, in seeking a common pattern or pathological mechanism of disease.
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Introduction
Connexins (Cxs) are a family of transmembrane (TM) proteins formed by 21 members (Eiberger
et al., 2001; Söhl and Willecke, 2004) named according to their predicted molecular weight (i.e.,
Cx43 has ∼43 kDa). Cxs are expressed in almost every cell type in the human body (Bruzzone
et al., 1996). However, there are some diﬀerences. Thus, for example, there are Cxs widely expressed
such as Cx43, which is found in the brain, kidneys, heart and reproductive organs, among others
(Beyer et al., 1987, 1989; Sáez et al., 2003), or restricted to myelin-forming glial cells, as in
the case of Cx29 (Söhl et al., 2001). Cxs form two types of channels; hemichannels (HCs) and
gap junction channels (GJCs). HCs are formed by the oligomerization of six Cxs monomers
and travel in vesicles to the plasma membrane (Vinken et al., 2006). The Cx topology in cell
membrane is depicted in Figure 1 and includes four TM segments (TM1-4), which are connected
through two extracellular loops (EL1-EL2) and one intracellular loop (IL); and the N-terminal
(NT) and C-terminal (CT) segments oriented to the cytosol (Kumar and Gilula, 1996). HCs can
form GJC in the appositional membranes of contacting cells or stay as “free” HCs anywhere on
the plasma membrane (Figure 2). Free HCs are mostly closed under physiological conditions
(Contreras et al., 2003), that is because they have low open probability (OP) due to one or
more of the following mechanisms: (i) a blockage by extracellular Ca2+ and Mg2+ in the mM
range, (ii) a negative membrane potential that closes most Cx HCs and (iii) posttranslational
modiﬁcation (i.e., phosphorylation) of some Cxs (Contreras et al., 2003; Gómez-Hernández et al.,
2003; Johnstone et al., 2012). However, HCs can open under physiological conditions allowing
communication between extracellular and intracellular space (Sáez et al., 2010). On the other
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FIGURE 1 | Topology of connexin (Cx) at the plasma membrane.
Cartoon depicting the plasma membrane topology shared by all Cx isoforms,
which includes four transmembrane (TM) segments that are connected by two
extracellular loops (ELs) and one intracellular loop (IL). The amino terminal (NT)
and carboxi terminal (CT) segments of each hemichannel face the cytoplasm.
The length of the NT and CT segments is not intended to represent any
particular Cx isoform.
FIGURE 2 | Plasma membrane arrangements of Cxs. Six Cxs oligomerize
to form a HC that traveled to the non-appositional plasma membrane to form
free HCs, which provide an auto/paracrine communication pathway between
the cell and the extracellular milieu. Alternatively, can dock others HCs
provided by an adjacent cell (appositional plasma membrane) to form
intercellular aqueous pore named gap junction channels.
hand, GJCs are formed in the appositional membrane by the
serial docking of two complementary HCs, each one in the
respective neighboring cell membrane (Figure 2). GJCs allow
the intercellular exchange of ions and molecules such as glucose
and amino acids between contacting cells (Payton et al., 1969;
Goldberg et al., 2004; Ek-Vitorin and Burt, 2013). Because of
these properties, Cx based channels have been associated with
diﬀerent cellular processes such as cellular communication and
tissue coordination (Sáez et al., 2010).
Role of HCs in Physiological Conditions
HCs have an estimated pore diameter ranging from 12 to 15 Å
in its narrowest part (Oh et al., 1997; Gong and Nicholson,
2001; Rackauskas et al., 2010). The crystal structure of Cx26
channels shows that the NT is inside the pore, a factor that
restricts the pore diameter (Maeda et al., 2009). However, recent
reﬁnements of this structure using molecular dynamic methods
suggest that the pore diameter could be a little smaller (Kwon
et al., 2011). Much experimental evidence shows that opening
of HCs activates pathways linked to the release or uptake
of paracrine and autocrine molecules such as: ATP (Anselmi
et al., 2008 (Cx26); Svenningsen et al., 2013 (Cx30); Nualart-
Marti et al., 2013 (Cx32); Schock et al., 2008 (Cx36); Stout
et al., 2002 (Cx43)), glutamate (Takeuchi et al., 2006 (Cx32);
Ye et al., 2003 (Cx43)), PGE2 (Cherian et al., 2005 (Cx43)),
NAD+ (Bruzzone et al., 2001 (Cx43)) and glutathione (Rana
and Dringen, 2007 (Cx43)). HCs may also mediate uptake of
glucose as well as extracellular ions. (Retamal et al., 2007 (Cx43);
Schalper et al., 2010 (Cx43); Sánchez et al., 2010 (Cx26); Fiori
et al., 2012 (Cx26)). Research about HC permeability has been
focused mostly on homomeric HCs made by Cx26, Cx32 and
Cx43. However, most cell types express more than one Cx
isoform, opening the possibility for the formation of heteromeric
channels that would present new permeability properties (Beyer
et al., 2001; Martinez et al., 2002). For example, it is known
that heteromeric HCs formed by Cx26/32 (1:1 ratio) exhibits
decreased permeability to (1,4,5)-IP3 compared to the respective
homomeric types formed by Cx26 or Cx32 (Ayad et al., 2006).
Additionally, information about the in vivo release of molecules
through HCs is currently very limited. However, data available
suggest that HCs are somehow involved in diﬀerent physiological
processes, such as the control of monocyte adhesion in mice
(Wong et al., 2006), neurotransmitter release from astrocytes in
the basolateral amygdala (Stehberg et al., 2012), Ca2+ signaling
in adult ventricular myocytes (Li et al., 2012), sensory neuron
activity (Retamal et al., 2014b), and bone cell physiology and
pathology (Plotkin, 2014). Moreover, HCs may also participate in
the ATP release from astrocytes to regulate basal glutamatergic
synaptic transmission (Chever et al., 2014), in the control of
colonic transit (McClain et al., 2014), in wound healing (Takada
et al., 2014), in renal function (Sipos et al., 2009), ion ﬂux
in lens cells (Beyer and Berthoud, 2014; Mandal et al., 2015)
and in the visual processing of the retina (Kamermans et al.,
2001). The signaling and molecular mechanisms that control
the opening of HCs under physiological conditions are poorly
understood. But, at least for Cx43 HCs, one possible mechanism
involves interactions between the CT and some regions of the IL
(Ponsaerts et al., 2010, 2012).
The presence and functional state of HCs in the plasma
membrane have been determined through several techniques,
including, dye uptake of ﬂuorescent molecules, release of
substances such as ATP, electrophysiology, biotinylation,
immunolocalization (Schalper et al., 2008; Wang et al., 2013a;
García et al., 2015). Because the existence of other non-selective
channels with big pores, like Pannexin channels, which share
several characteristics with Cx HCs, there are some criterions
that need to be considered in order to demonstrate unique
functional properties of Cx HCs (Sáez and Leybaert, 2014).
Among these criterions are: (i) cell expression of at least one
Cx isoform at the plasma membrane, (ii) the ability of the
cells to incorporate/release ﬂuorescent dyes, and /or (iii) to
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show currents with conductance and/or properties associated
to Cx HCs, (iv) the abolishment of Cx-HCs function using
classical pharmacology (La3+, meﬂoquine, carbenoxolone) or
Cx mimetic peptides (Gap 26, 27); and ﬁnally (v) to demonstrate
that blocking Cx HCs exerts physiological responses.
Leaky HCs
Paul et al. (1991) provided the ﬁrst evidence linking HCs with
cell death, they observed that overexpression of Cx46 in Xenopus
laevis oocytes, induces depolarization and lysis of oocytes 24 h
after mRNA injection. Interestingly, cell death did not occur
when other Cxs, like Cx32 or Cx43 were overexpressed. Later on,
it was demonstrated that human Cx43 does not form functional
HCs in Xenopus oocytes (Hoang et al., 2010), suggesting that
formation of functional HCs depends on both Cx isoform
and cell type. On the other hand, several works have shown
that many pathological conditions produce uncontrolled and
massive HC opening (from now called leaky HCs), which
may adversely aﬀect cellular homeostasis and induce cell death
(Sáez et al., 2010). For example, it was reported that infection
of the gastrointestinal tract increases Cx43 HC activity in
colonocytes, which was correlated with an increase of water
mobilization and appearance of diarrhea, which can be reverted
by down-regulating gut expression level of Cx43 (Guttman et al.,
2010). In addition, natural occurring Cx mutations have been
associated with diﬀerent human genetic diseases such as cataract,
skin diseases, deafness, X-linked Charcot–Marie–Tooth disease,
and oculodentodigital dysplasia (ODDD; Table 1). Some Cx
mutations in these diseases produce leaky HCswhen expressed in
heterologous expression systems. Here, we will review the current
knowledge about these leaky HCs and their possible pathologic
mechanisms of disease.
Cataract
Lens cells express Cx43, Cx46, and Cx50 (Beyer and Berthoud,
2014). Until now, Cx43 mutations have not been associated
with cataract formation; however, the lack or malfunctioning
of Cxs 46 and 50 has been associated with the development
of diﬀerent types of cataracts (Beyer and Berthoud, 2014).
Accordingly, the expression of Cx50G46V mutant in Xenopus
oocytes induces large HC currents at physiological extracellular
Ca2+ concentration (Tong et al., 2011). In addition, this mutant
TABLE 1 | Connexin (Cx) mutations associated to leaky HCs.
Cx Mutation Localization Type of disease Reference
Skin and inner ear Cx26 G12R NT Keratitis-ichthyosis-deafness (KID) syndrome Lee et al. (2009)
N14K NT Keratitis-ichthyosis-deafness syndrome Lee et al. (2009)
N14Y NT Keratitis-ichthyosis-deafness syndrome García et al. (2015)
A40V TM1/EL1 Keratitis-ichthyosis-deafness syndrome Sanchez et al. (2014)
G45E TM1/EL1 Keratitis-ichthyosis-deafness syndrome Stong et al. (2006), Gerido et al. (2007)
D50N EL1 Keratitis-ichthyosis-deafness syndrome Lee et al. (2009)
D50A EL1 Keratitis-ichthyosis-deafness syndrome Mhaske et al. (2013)
A88V TM2 Keratitis-ichthyosis-deafness syndrome Mhaske et al. (2013)
Skin Cx30 G11R NT Hidrotic ectodermal dysplasia Essenfelder et al. (2004)
A88V TM2 Hidrotic ectodermal dysplasia Essenfelder et al. (2004)
Cx31 R42P TM1/EL1 Erythrokeratodermia variabilis Chi et al. (2012)
CX43 G8V NT Keratoderma-hypotrichosis-leukonychia totalis syndrome Wang et al. (2015)
Lens Cx46 G2D NT Nuclear pulverulent and posterior polar cataracts Yao et al. (2011)
G143R IL Coppock cataracts Ren et al. (2013)
Cx50 V44A TM1/EL1 Suture-sparing nuclear cataracts Zhu et al. (2014)
G46V E1 Cataract Tong et al. (2011)
Nervous system Cx32 F235C CT Charcot–Marie–Tooth disease Liang et al. (2005)
S85C TM2 Charcot–Marie–Tooth disease Abrams et al. (2002)
Cx43 G60S EL1 Oculodentodigital dysplasia Kozoriz et al. (2013)
G138R IL Oculodentodigital dysplasia Dobrowolski et al. (2008)
Heart Cx40 G38D TM1 Chronic atrial fibrillation Patel et al. (2014)
V85I TM2 Atrial fibrillation Sun et al. (2014)
L211I TM4 Atrial fibrillation Sun et al. (2014)
Cx43 I31M TM1 Spontaneous arrhythmias Dobrowolski et al. (2007)
G138R IL Spontaneous arrhythmias Dobrowolski et al. (2007)
G143S IL Spontaneous arrhythmias Dobrowolski et al. (2007)
Leaky HCs can result from single point mutations. Mutations in different Cxs can lead the development of different diseases with hallmark characteristics. Note that most
mutations leading to formation of leaky HCs are located in the N- terminus (NT), the extracellular loop 1 (EL1) and transmembrane domains 1 and 2 (TM1 and TM2). In a
lesser extent, some mutations are found in the intracellular loop (IL) or the transmembrane domain 3 and 4 (TM3 and TM4). In terms of leaky HCs, mutations in C-terminal
are rarer, probably because the first half of the protein including (NT, TM1, EL1, TM2 and IL) is much more important in terms of pore formation, permeability and voltage
gating.
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promotes cell death when expressed in HeLa cells, which was
prevented by the increase of the extracellular Ca2+ concentration
(Minogue et al., 2009). Similarly, Cx50V44Amutant also induces
HeLa cell death, which was reduced by HC blockers (Zhu
et al., 2014). The aforementioned data suggest that some Cx50
mutations located closely to the TM1 and EL1 border result in
formation of leaky HCs, which cause cataracts when expressed
in humans. Additionally, diﬀerent Cx46 mutations have been
associated with leaky HCs. For example, mutant Cx46G143R
(located in the IL) leads to the appearance of Coppock cataracts
(Ren et al., 2013), and mutant Cx46G2D (located the NT) has
been linked to formation of nuclear pulverulent and posterior
polar cataracts (Yao et al., 2011). Lower plasma membrane
expression of these mutants was enough to promote cell death
when expressed in HeLa cells (Ren et al., 2013). This suggests that
mutation Cx46G143R induces an important increase in the HC
activity, possibly by modifying the interaction between the CT
and IL, which is associated with HC opening (Ren et al., 2013).
A possible explanation for the pathological mechanism of leaky
Cx46 HCs is that the opening of these channels produces an
excessive ﬂow of Ca2+ through the plasma membrane (Ebihara
et al., 2014; Mandal et al., 2015), which should perturb the normal
ionic balance of lens cells (Figure 3).
Skin Diseases and Deafness
Several Cx types such as Cx26, Cx30, Cx30.3, Cx31.1, Cx37, and
Cx43 are diﬀerentially expressed in the skin (Scott et al., 2012).
On the other hand, while in the inner ear the sensory hair cells
do not express Cxs, several Cxs (Cxs 26, 29, 30, 31, 43) are
expressed in supporting epithelial cells of the organ of Corti, stria
vascularis and in the interstitial cellular network that compose
the wall of the scala media (Martínez et al., 2009). However, until
now, only mutations in Cx26 gene are associated to syndromic
(deafness plus skin disease) and non-syndromic deafness (Hoang
Dinh et al., 2009; Martínez et al., 2009). Currently it is known
that several missense point mutation in Cx26 – G12R, N14K,
N14Y, A40V, G45E, D50N, D50A and A88V do form leaky HCs
and induce both skin and hearing disorders, which together are
known as keratitis-ichthyosis-deafness (KID) syndrome (Stong
et al., 2006; Gerido et al., 2007; Lee et al., 2009; García et al.,
2013; Mhaske et al., 2013; Meigh et al., 2014; Sanchez et al.,
2014). Interestingly, García et al. (2015) showed that the mutant
Cx26S17F presents decreased HC activity when expressed alone
in Xenopus oocytes, but when is co-expressed with Cx43 [which
does not form functional HCs in Xenopus oocytes (Hansen et al.,
2014)], a large HC current is then evident (García et al., 2015).
Because of these leaky HCs, HeLa cells expressing Cx26S17F
and Cx43 showed almost twice the basal intracellular Ca2+
concentration (García et al., 2015). These results could explain
the resulting KID syndrome of the mutant S17F, since in the
human skin Cx26 and Cx43 are co-expressed in keratinocytes
of the stratum basal (Wang et al., 2009). In addition, certain
mutations located in the EL1 also produce leaky HCs, such as
D50N, that change the Ca2+ control over HC activity through
the modiﬁcation of a salt bridge between D50 and K61, which
is important for HC closure induced by extracellular Ca2+
(Lopez et al., 2013; Sanchez et al., 2013). Consistently, a similar
mutation (Cx26D50A) also induces leaky HC and produce KID
syndrome (Mhaske et al., 2013). On the other hand, mutant
Cx26A40V, located in the TM1/EL1 border, increases HC activity
FIGURE 3 | Representation of the effects of leaky HC. Under normal
conditions (upper panel) HCs present a low open probability (OP). Thus, when
HCs are normally closed (t0, low OP), no exchange with the extracellular milieu
is observed. However, when HCs open (t1, higher OP), molecules such as ATP
and Ca2+ can flow through them. Calcium may activate intracellular pathways,
and ATP released from the cell, can act as a paracrine -or autocrine- signal,
hence, the cell is at a communicating state. In contrast leaky HCs (lower
panel) maintain a high OP, producing a continuous flow out and into the cell.
Leaky HCs exchange continuously, resulting in the reduction of cell membrane
potential and later cell death (t2).
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by decreasing sensitivity to pH and divalent cations (Sanchez
et al., 2014). However, other mutation in the same residue
(A40G) produced non-functional HCs (Jara et al., 2012) and
severe deafness without skin disease, suggesting that this residue
is positioned in a pivotal region for HC gating control. Another
mutant associated with KID syndrome, Cx26G45E (Griﬃth et al.,
2006) also induces large HC currents or dye uptake that leads to
cell death when expressed in Xenopus oocytes or HEK293 cells
(Stong et al., 2006; Gerido et al., 2007). The phenotype induced
by the Cx26G45E mutant could be the result of a lack of Ca2+
control (Zhang and Hao, 2013), reﬂected by enhanced Ca2+
permeability in cells expressing this mutant (Sanchez et al., 2014).
In a mousemodel, Cx26G45E induces a reduction of cell viability,
hyperkeratosis, scaling, skinfolds, and hair loss (Mese et al., 2011).
These data suggest that leaky Cx26HCs can induce skin problems
and deafness, probably due to misregulation of intracellular Ca2+
homeostasis and ATP release (García et al., 2015) (Figure 3);
both conditions could aﬀect many cellular processes, such as
abnormal keratinocyte proliferation and cell death. Although,
most mutations in Cx26 associated with deafness produce lack
of function GJCs, only syndromic mutations produce gain of
HC activity (Martínez et al., 2009; García et al., 2013). However,
since syndromic mutations also aﬀect GJCs, the pathogenic
mechanism of disease may involve deregulation of both types
of channels, which is a condition that would worsen the cellular
homeostasis (García et al., 2015).
Mutations in Cx30 have been also linked to skin disease.
Thus, mutants of Cx30- G11R (NT) and A88V (TM2) has
been associated with Clouston syndrome (abnormal formation of
ectodermal structures) and when they are expressed in HeLa cells
induce a massive release of ATP into the extracellular medium
(Essenfelder et al., 2004) and subsequent cell death (Berger et al.,
2014), suggesting uncontrolled HC activity. On the other hand,
the mutant Cx31R42P (which produces erythrokeratodermia
variabilis) promotes an enhancement in HC activity and cell
death when expressed in HeLa cells (Chi et al., 2012). It
was postulated that the previous condition was mediated by
an important production of free radicals as consequence of
ER stress (Chi et al., 2012). Recently, a mutation in Cx43
(Cx43G8V) has been associated to keratoderma-hypotrichosis-
leukonychia totalis syndrome (KHLS), a condition characterized
by hyperkeratosis and alopecia, the expression of this mutant
induced gain in HC activity and Ca2+ inﬂux into the cells (Wang
et al., 2015).
X-linked Charcot–Marie–Tooth Disease
This neuropathy is a hereditary disease caused by diﬀerent
mutations in Cx32 gene (Bergoﬀen et al., 1993). There are
several Cx32 mutations that induce Charcot–Marie–Tooth
disease (Liang et al., 2005). Patients with this disease present
neurodegeneration due to alteredmyelin production by Schwann
cells (Bergoﬀen et al., 1993). When the mutation Cx32F235C
(CT) is expressed in Xenopus oocytes, it induces cell death after
72 h, which was associated with changes in its voltage sensitivity
(Liang et al., 2005). In addition, the other pathological mutant
Cx32S85C induces a decrease in the number of HCs at the
plasma membrane (measured as biotinylated protein). However,
when this mutant was expressed in oocytes, larger HC currents
were observed under depolarization (Abrams et al., 2002). Thus,
several mutations induce this disease, but to date only two of
them have been reported to form leaky HCs.
Oculodentodigital dysplasia
It is a dominant negative inherited disorder caused by mutations
in Cx43 encoding gene. ODDD’s patients exhibit abnormalities
in ﬁngers, toes, eyes, face and teeth. Mice expressing human
mutations Cx43- G138R or G60S, mimic the phenotype observed
in humans (Dobrowolski et al., 2008; Kozoriz et al., 2013). In
the case of mice +/G60S, the area of cell death induced by
brain ischemia was bigger compared to control mice; accordingly,
astrocytes cultured from +/G60S mice, show enhanced HC
activity (Kozoriz et al., 2013). In the other hand, mutant
Cx43G138R lacks one of the typical phosphorylated forms
of Cx43 (P2), and cells extracted from the +/G138R mice
present increased ATP release (Dobrowolski et al., 2008). The
previous results were consistent with the hypothesis that the
phosphorylation state of the Cx43 CT regulates Cx43 HC activity.
Heart Disease
Heart cells express Cx40, Cx43, and Cx45. However, their
respective expression is restricted to few types of cells in the
heart (Bai, 2014). For example, Cx40 is expressed only in
the atria and ventricular conduction system, while Cx43 is
mostly expressed in cardiomyocytes (Bai, 2014). Several Cx40
mutations have been associated with atrial-ﬁbrillation problems,
but only mutants Cx40- G38D, V85I and L211I enhance HC
activity (Patel et al., 2014; Sun et al., 2014). In the case
of G38D, it was found that HCs formed by this mutant
present a gain of activity when N2A cells were subjected to
hyperpolarization and depolarization (Patel et al., 2014). Cx43-
I31M, G143S and G138R mutants (which also induce ODDD),
present spontaneous arrhythmias, which were associated with
both, a decrease of GJC coupling and an increase of ATP
release from cardiomyocytes (Dobrowolski et al., 2007). A few
years ago, it was demonstrated that down-regulation of Cx43
in cardiac ﬁbroblasts reduce the amount of ATP released (Lu
et al., 2012). The ATP released activates the pro-ﬁbrotic response
to heart insults via activation of P2Y receptors (Lu et al.,
2012). Thus, increased Cx43 HC activity after -for example-
myocardial infarction (John et al., 1999; Johansen et al., 2011)
will lead to cardiomyocyte malfunction due to a massive entry
of Ca2+ and Na+ (Li et al., 2001). In addition, it will also
contribute to cardiac ﬁbrosis (Lu et al., 2012) increasing heart
failure.
Central Nervous System
Neurodegenerative Diseases
Under physiological conditions HCs participate in important
functions of the nervous system (NS), as for example, in synaptic
modulation (Stehberg et al., 2012; Chever et al., 2014). Moreover,
it has been shown that some pathological conditions increase
HC activity, in particular the activity of astrocyte HCs formed by
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 July 2015 | Volume 9 | Article 267
Retamal et al. Leaky hemichannels
Cx43, which have been correlated with neuronal malfunctioning
and death (Orellana et al., 2012). When an ischemic episode
occurs, astrocytes open their Cx43 HCs (Contreras et al., 2002;
Retamal et al., 2006), probably due to dephosphorylation and
S-nitrosylation of Cx43 (Retamal et al., 2006). The previous
conditions induce a massive opening of astrocyte Cx43 HCs
allowing the release of high amounts of ATP and glutamate
from astrocytes (Orellana et al., 2011a; Li et al., 2015). This
increment in extracellular ATP and glutamate concentration
could induce the opening of neuronal Pannexin1 channels,
perturbing neuron homeostasis causing cell death (Orellana
et al., 2011a). Consistently, administration of Cx43 mimetic
peptides, to block HCs, improved brain recovery after ischemia
in fetal sheep (Davidson et al., 2012) and neonatal rats (Li et al.,
2015).
Hyperactive HCs may also be involved in other brain
diseases. Lysosomal storage diseases (LSDs) encompass a large
group of inherited metabolic disorders characterized by the
accumulation of storage material within lysosomes and HCs
seems to have a relevant role in the progression of these
diseases (Bosch and Kielian, 2014). In this line, an enhanced
Cx43 HC activity was observed in astrocytes from a mouse
model of LSD (CLN3ex7/8; Finn et al., 2011; Burkovetskaya
et al., 2014) which could importantly contribute to neuronal
deterioration as mentioned above. On the other hand, opening
of HCs could also contribute to brain deterioration in
Alzheimer’s disease. Orellana et al. (2011b) reported that Aβ
peptide induces massive HC opening in astrocytes, microglia,
and neurons, either in culture and in hippocampal slices
(Orellana et al., 2011b). This increase of HC activity is
correlated with augmented release of neuroactive molecules,
such as glutamate and ATP, with induction of cellular death
(Orellana et al., 2011b; Bosch and Kielian, 2014). Accordingly,
blockage of HCs improved memory impairment in a mouse
model of Alzheimer’s disease (Takeuchi et al., 2011). Other
neurodegenerative diseases in which HC have been involved
are: HIV encephalitis (Eugenin and Berman, 2013; Orellana
et al., 2014), amyotrophic lateral sclerosis (Boillee et al., 2006;
Yamanaka et al., 2008; Takeuchi et al., 2011), Parkinson’s
disease (Rufer et al., 1996; Kawasaki et al., 2009), Rasmussen
encephalitis (Cepeda et al., 2015) and epilepsy (Mylvaganam
et al., 2014). A common milestone of these diseases is the
inﬂammation condition, where cytokines and reactive oxygen
species (ROS) can activate HCs in glial cells (astrocytes and
microglia; Retamal et al., 2007) increasing the extracellular
concentration of compounds, like ATP and glutamate, that could
indirectly open Pannexin1 channels leading to neuronal death
(Orellana et al., 2012; Bosch and Kielian, 2014; Takeuchi and
Suzumura, 2014).
Future Directions
When opened in a controlled fashion, CxHCs allow physiological
paracrine and autocrine communication between neighboring
cells. However, under certain pathological conditions, these HCs
open more frequently, inducing ionic imbalance and cell lysis.
In particular, speciﬁc missense mutations in Cx genes associated
with human genetic disease produce leaky HCs, a condition
that perturbs ionic cell homeostasis, increases ATP release and
Ca2+ inﬂux, which in the extreme condition leads to cell death.
Probably, the major problem in the study of Cx- based channels
is the lack of speciﬁc pharmacological tools able to block or open
these channels. Thus, for example, one of the most used HC
blockers is La3+ (usually used at 200 μM), but this lanthanide
also blocks TRP channels (Zhao et al., 2015), cGMP-activated
currents (Wang et al., 2013b) and Ca2+ channels (Nelson
et al., 1984). Fortunately, in the last years new tools have been
developed for the study of Cx- HCs. These are based on small
peptides that mimic some regions of a given Cx (Iyyathurai et al.,
2013). Through the use of these mimetic peptides it has been
possible to study in vitro/in vivo the role of HCs in a much more
speciﬁc way. Because of their speciﬁcity and high aﬃnity, they
could be used for the treatment of diseases associated with leaky
HCs. In this line of thought, mimetic peptides Gap26 or Gap27
have been observed to block cardiomyocyte death induced by
ischemic-like conditions in vitro (Shintani-Ishida et al., 2007) as
well as in vivo (Hawat et al., 2012). In the NS, Gap26 and Gap27
peptides blocked Cx43 HC opening induced by inﬂammatory
conditions (Retamal et al., 2007; Froger et al., 2010), while
Gap27 reduced spontaneous epileptiform activity in organotypic
hippocampal slice cultures and cell death associated with this
activity (Samoilova et al., 2008; Yoon et al., 2010). On the other
hand, mimetic peptide Gap26 inhibits the spread of damage from
the trauma zone to the penumbra in an in vitro model (Rovegno
et al., 2015). Similar results have been observed in vivo in a model
of spinal cord injury (Huang et al., 2008; O’Carroll et al., 2008)
and post-ischemic brain injury (Davidson et al., 2012). Moreover,
inhibition of Cx43 HCs with mimetic peptides in the spinal cord,
signiﬁcantly reduced the sensitization to neuropathic pain (Chen
et al., 2014), which suggests that opening of HCs could result
in an excessive release of neuroactive molecules in chronic pain.
Accordingly, exposure of sensory ganglia to mimetic peptides, to
block Cx43 HCs of satellite glial cells, reduced sensory neuron
activity (Retamal et al., 2014a,b). Therefore, mimetic peptides
could be used as the starting point to develop new and more
speciﬁc pharmacologic agents to inhibit HCs to treat human
diseases associated to leaky HCs.
Acknowledgments
We would like to thank Ms. Carolina Larrain for her
corrections and comments performed on our manuscript. Also,
we want to thank the ﬁnancial support from the following
sources: Fondecyt #1120214 and Anillo #ACT 1104 (to MR),
Fondecyt #1130855 (to ADM), Fondecyt 1120802 (to CG) and
Fondecyt 3150634 (to IG). The Centro Interdisciplinario de
Neurociencias de Valparaíso is a Chilean Millennium Institute
(P09-022-F).
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 July 2015 | Volume 9 | Article 267
Retamal et al. Leaky hemichannels
References
Abrams, C. K., Bennett, M. V., Verselis, V. K., and Bargiello, T. A. (2002). Voltage
opens unopposed gap junction hemichannels formed by a connexin 32 mutant
associated with X-linked Charcot-Marie-Tooth disease. Proc. Natl. Acad. Sci.
U.S.A. 99, 3980–3984. doi: 10.1073/pnas.261713499
Anselmi, F., Hernandez, V. H., Crispino, G., Seydel, A., Ortolano, S., Roper,
S. D., et al. (2008). ATP release through connexin hemichannels and gap
junction transfer of second messengers propagate Ca2+ signals across the inner
ear. Proc. Natl. Acad. Sci. U.S.A. 105, 18770–18775. doi: 10.1073/pnas.0800
793105
Ayad, W. A., Locke, D., Koreen, I. V., and Harris, A. L. (2006). Heteromeric,
but not homomeric, connexin channels are selectively permeable to
inositol phosphates. J. Biol. Chem. 281, 16727–16739. doi: 10.1074/jbc.M600
136200
Bai, D. (2014). Atrial ﬁbrillation-linked GJA5/connexin40 mutants impaired
gap junctions via diﬀerent mechanisms. FEBS Lett. 588, 1238–1243. doi:
10.1016/j.febslet.2014.02.064
Berger, A. C., Kelly, J. J., Lajoie, P., Shao, Q., and Laird, D. W. (2014). Mutations in
Cx30 that are linked to skin disease and non-syndromic hearing loss exhibit
several distinct cellular pathologies. J. Cell Sci. 127(Pt 8), 1751–1764. doi:
10.1242/jcs.138230
Bergoﬀen, J., Scherer, S. S., Wang, S., Scott, M. O., Bone, L. J., Paul, D. L., et al.
(1993). Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science
262, 2039–2042. doi: 10.1126/science.8266101
Beyer, E. C., and Berthoud, V.M. (2014). Connexin hemichannels in the lens. Front.
Physiol. 5:20. doi: 10.3389/fphys.2014.00020
Beyer, E. C., Gemel, J., Martínez, A., Berthoud, V. M., Valiunas, V., Moreno,
A. P., et al. (2001). Heteromeric mixing of connexins: compatibility of
partners and functional consequences. Cell Commun. Adhes. 8, 199–204. doi:
10.3109/15419060109080723
Beyer, E. C., Kistler, J., Paul, D. L., and Goodenough, D. A. (1989). Antisera
directed against connexin43 peptides react with a 43-kD protein localized to
gap junctions in myocardium and other tissues. J. Cell Biol. 108, 595–605. doi:
10.1083/jcb.108.2.595
Beyer, E. C., Paul, D. L., and Goodenough, D. A. (1987). Connexin43: a protein
from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 105,
2621–2629. doi: 10.1083/jcb.105.6.2621
Boillee, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A.,
Kassiotis, G., et al. (2006). Onset and progression in inherited ALS
determined by motor neurons and microglia. Science 312, 1389–1392. doi:
10.1126/science.1123511
Bosch, M., and Kielian, T. (2014). Hemichannels in neurodegenerative
diseases: is there a link to pathology? Front. Cell. Neurosci. 8:242. doi:
10.3389/fncel.2014.00242
Bruzzone, S., Guida, L., Zocchi, E., Franco, L., and De Flora, A. (2001). Connexin 43
hemi channels mediate Ca2+-regulated transmembrane NAD+ ﬂuxes in intact
cells. FASEB J. 15, 10–12.
Bruzzone, R., White, T. W., and Paul, D. L. (1996). Connections with connexins:
the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238, 1–27.
doi: 10.1111/j.1432-1033.1996.0001q.x
Burkovetskaya, M., Karpuk, N., Xiong, J., Bosch, M., Boska, M. D., Takeuchi, H.,
et al. (2014). Evidence for Aberrant astrocyte hemichannel activity in
juvenile neuronal ceroid lipofuscinosis (JNCL). PLoS ONE 9:e95023.
doi: 10.1371/journal.pone.0095023
Cepeda, C., Chang, J. W., Owens, G. C., Huynh, M. N., Chen, J. Y., Tran, C., et al.
(2015). In Rasmussen encephalitis, hemichannels associated with microglial
activation are linked to cortical pyramidal neuron coupling: a possible
mechanism for cellular hyperexcitability. CNS Neurosci. Ther. 21, 152–163. doi:
10.1111/cns.12352
Chen, G., Park, C. K., Xie, R. G., Berta, T., Nedergaard, M., and Ji, R. R.
(2014). Connexin-43 induces chemokine release from spinal cord astrocytes to
maintain late-phase neuropathic pain in mice. Brain 137(Pt 8), 2193–2209. doi:
10.1093/brain/awu140
Cherian, P. P., Siller-Jackson, A. J., Gu, S., Wang, X., Bonewald, L. F., Sprague, E.,
et al. (2005).Mechanical strain opens connexin 43 hemichannels in osteocytes: a
novel mechanism for the release of prostaglandin.Mol. Biol. Cell 16, 3100–3106.
doi: 10.1091/mbc.E04-10-0912
Chever, O., Lee, C. Y., and Rouach, N. (2014). Astroglial connexin43 hemichannels
tune basal excitatory synaptic transmission. J. Neurosci. 34, 11228–11232. doi:
10.1523/JNEUROSCI.0015-14.2014
Chi, J., Li, L., Liu, M., Tan, J., Tang, C., Pan, Q., et al. (2012). Pathogenic connexin-
31 forms constitutively active hemichannels to promote necrotic cell death.
PLoS ONE 7:e32531. doi: 10.1371/journal.pone.0032531
Contreras, J. E., Sáez, J. C., Bukauskas, F. F., and Bennett, M. V. (2003). Gating and
regulation of connexin 43 (Cx43) hemichannels. Proc. Natl. Acad. Sci. U.S.A.
100, 11388–11393. doi: 10.1073/pnas.1434298100
Contreras, J. E., Sánchez, H. A., Eugenin, E. A., Speidel, D., Theis, M., Willecke, K.,
et al. (2002). Metabolic inhibition induces opening of unapposed connexin
43 gap junction hemichannels and reduces gap junctional communication in
cortical astrocytes in culture. Proc. Natl. Acad. Sci. U.S.A. 99, 495–500. doi:
10.1073/pnas.012589799
Davidson, J. O., Green, C. R., Nicholson, L. F., O’Carroll, S. J., Fraser, M., Bennet, L.,
et al. (2012). Connexin hemichannel blockade improves outcomes in a model
of fetal ischemia. Ann. Neurol. 71, 121–132. doi: 10.1002/ana.22654
Dobrowolski, R., Sasse, P., Schrickel, J. W.,Watkins, M., Kim, J. S., Rackauskas, M.,
et al. (2008). The conditional connexin43G138R mouse mutant represents a
new model of hereditary oculodentodigital dysplasia in humans. Hum. Mol.
Genet. 17, 539–554. doi: 10.1093/hmg/ddm329
Dobrowolski, R., Sommershof, A., andWillecke, K. (2007). Some oculodentodigital
dysplasia-associated Cx43 mutations cause increased hemichannel activity in
addition to deﬁcient gap junction channels. J. Membr. Biol. 219, 9–17. doi:
10.1007/s00232-007-9055-7
Ebihara, L., Korzyukov, Y., Kothari, S., and Tong, J. J. (2014). Cx46 hemichannels
contribute to the sodium leak conductance in lens ﬁber cells.Am. J. Physiol. Cell
Physiol. 306, C506–C513. doi: 10.1152/ajpcell.00353.2013
Eiberger, J., Degen, J., Romualdi, A., Deutsch, U., Willecke, K., and Söhl, G. (2001).
Connexin genes in the mouse and human genome. Cell Commun. Adhes. 8,
163–165. doi: 10.3109/15419060109080717
Ek-Vitorin, J. F., and Burt, J. M. (2013). Structural basis for the selective
permeability of channels made of communicating junctionproteins. Biochim.
Biophys. Acta 1828, 51–68. doi: 10.1016/j.bbamem.2012.02.003
Essenfelder, G.M., Bruzzone, R., Lamartine, J., Charollais, A., Blanchet-Bardon, C.,
Barbe, M. T., et al. (2004). Connexin30 mutations responsible for hidrotic
ectodermal dysplasia cause abnormal hemichannel activity. Hum. Mol. Genet.
13, 1703–1714. doi: 10.1093/hmg/ddh191
Eugenin, E. A., and Berman, J. W. (2013). Cytochrome c dysregulation induced
by HIV infection of astrocytes results in bystander apoptosis of uninfected
astrocytes by an IP3 and calcium-dependent mechanism. J. Neurochem. 127,
644–651. doi: 10.1111/jnc.12443
Finn, R., Kovacs, A. D., and Pearce, D. A. (2011). Altered sensitivity of cerebellar
granule cells to glutamate receptor overactivation in the Cln3(Deltaex7/8)-
knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. Neurochem.
Int. 58, 648–655. doi: 10.1016/j.neuint.2011.02.003
Fiori, M. C., Figueroa, V., Zoghbi, M. E., Saéz, J. C., Reuss, L., and Altenberg, G. A.
(2012). Permeation of calcium through puriﬁed connexin 26 hemichannels.
J. Biol. Chem. 287, 40826–40834. doi: 10.1074/jbc.M112.383281
Froger, N., Orellana, J. A., Calvo, C. F., Amigou, E., Kozoriz, M. G., Naus,
C. C., et al. (2010). Inhibition of cytokine-induced connexin43 hemichannel
activity in astrocytes is neuroprotective. Mol. Cell. Neurosci. 45, 37–46. doi:
10.1016/j.mcn.2010.05.007
García, I. E., Maripillán, J., Jara, O., Ceriani, R., Palacios-Muñoz, A.,
Ramachandran, J., et al. (2015). Keratitis-ichthyosis-deafness syndrome-
associated Cx26 mutants produce nonfunctional gap junctions but hyperactive
hemichannels when co-expressed with wild type Cx43. J. Invest. Dermatol. 135,
1338–1347. doi: 10.1038/jid.2015.20
García, I. E., Retamal, M. A., Jara, O., González, C., and Martínez, A. D.
(2013). Is the gain of hemichannel activity a common feature shared by
Cx26 syndromic deafness mutants? Biophysical. J. 104, 492a–493a. doi:
10.1016/j.bpj.2012.11.2715
Gerido, D. A., DeRosa, A. M., Richard, G., and White, T. W. (2007). Aberrant
hemichannel properties of Cx26 mutations causing skin disease and deafness.
Am. J. Physiol. Cell Physiol. 293, C337–C345. doi: 10.1152/ajpcell.00626.2006
Goldberg, G. S., Valiunas, V., and Brink, P. R. (2004). Selective permeability
of gap junction channels. Biochim. Biophys. Acta 1662, 96–101. doi:
10.1016/j.bbamem.2003.11.022
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 July 2015 | Volume 9 | Article 267
Retamal et al. Leaky hemichannels
Gómez-Hernández, J.M., deMiguel,M., Larrosa, B., González, D., and Barrio, L. C.
(2003). Molecular basis of calcium regulation in connexin-32 hemichannels.
Proc. Natl. Acad. Sci. U.S.A. 100, 16030–16035. doi: 10.1073/pnas.2530348100
Gong, X. Q., and Nicholson, B. J. (2001). Size selectivity between gap junction
channels composed of diﬀerent connexins. Cell Commun. Adhes. 8, 187–192.
doi: 10.3109/15419060109080721
Griﬃth, A. J., Yang, Y., Pryor, S. P., Park, H. J., Jabs, E. W., Nadol, J. B. Jr.,
et al. (2006). Cochleosaccular dysplasia associated with a connexin 26 mutation
in keratitis-ichthyosis-deafness syndrome. Laryngoscope 116, 1404–1408. doi:
10.1097/01.mlg.0000224549.75161.ca
Guttman, J. A., Lin, A. E., Li, Y., Bechberger, J., Naus, C. C., Vogl, A. W., et al.
(2010). Gap junction hemichannels contribute to the generation of diarrhoea
during infectious entericdisease.Gut 59, 218–226. doi: 10.1136/gut.2008.170464
Hansen, D. B., Braunstein, T. H., Nielsen, M. S., and MacAulay, N. (2014). Distinct
permeation proﬁles of the connexin 30 and 43 hemichannels. FEBS Lett. 588,
1446–1457. doi: 10.1016/j.febslet.2014.01.036
Hawat, G., Hélie, P., and Baroudi, G. (2012). Single intravenous low-dose
injections of connexin 43 mimetic peptides protect ischemic heart in
vivo against myocardial infarction. J. Mol. Cell Cardiol. 53, 559–566. doi:
10.1016/j.yjmcc.2012.07.008
Hoang Dinh, E., Ahmad, S., Chang, Q., Tang, W., Stong, B., and Lin, X. (2009).
Diverse deafness mechanisms of connexin mutations revealed by studies
using in vitro approaches and mouse models. Brain Res. 1277, 52–69. doi:
10.1016/j.brainres.2009.02.008
Hoang, Q. V., Qian, H., and Ripps, H. (2010). Functional analysis of hemichannels
and gap-junctional channels formed by connexins 43 and 46. Mol. Vis. 16,
1343–1352.
Huang, C., Han, X., Li, X., Lam, E., Peng, W., Lou, N., et al. (2008). Critical role of
connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci.
32, 3333–3338. doi: 10.1523/JNEUROSCI.1216-11.2012
Iyyathurai, J., D’hondt, C., Wang, N., De Bock, M., Himpens, B., Retamal, M. A.,
et al. (2013). Peptides and peptide-derivedmolecules targeting the intracellular
domains of Cx43: gap junctions versus hemichannels. Neuropharmacology 75,
491–505. doi: 10.1016/j.neuropharm.2013.04.050
Jara, O., Acuña, R., García, I. E., Maripillán, J., Figueroa, V., Sáez, J. C.,
et al. (2012). Critical role of the ﬁrst transmembrane domain of Cx26 in
regulating oligomerization and function. Mol. Biol. Cell 23, 3299–3311. doi:
10.1091/mbc.E11-12-1058
Johansen, D., Cruciani, V., Sundset, R., Ytrehus, K., and Mikalsen, S. O.
(2011). Ischemia induces closure of gap junctional channels and opening
of hemichannels in heart-derived cells and tissue. Cell Physiol. Biochem. 28,
103–114. doi: 10.1159/000331719
John, S. A., Kondo, R., Wang, S. Y., Goldhaber, J. I., and Weiss, J. N. (1999).
Connexin-43 hemichannels opened by metabolic inhibition. J. Biol. Chem. 274,
236–240. doi: 10.1074/jbc.274.1.236
Johnstone, S. R., Billaud, M., Lohman, A. W., Taddeo, E. P., and Isakson, B. E.
(2012). Posttranslational modiﬁcations in connexins and pannexins. J. Membr.
Biol. 245, 319–332. doi: 10.1007/s00232-012-9453-3
Kamermans, M., Fahrenfort, I., Schultz, K., Janssen-Bienhold, U., Sjoerdsma, T.,
and Weiler, R. (2001). Hemichannel-mediated inhibition in the outer retina.
Science 292, 1178–1180. doi: 10.1126/science.1060101
Kawasaki, A., Hayashi, T., Nakachi, K., Trosko, J. E., Sugihara, K., Kotake, Y., et al.
(2009). Modulation of connexin 43 in rotenone-induced model of Parkinson’s
disease. Neuroscience 160, 61–68. doi: 10.1016/j.neuroscience.2009.01.080
Kozoriz, M. G., Lai, S., Vega, J. L., Sáez, J. C., Sin, W. C., Bechberger,
J. F., et al. (2013). Cerebral ischemic injury is enhanced in a model
of oculodentodigital dysplasia. Neuropharmacology 75, 549–556. doi:
10.1016/j.neuropharm.2013.05.003
Kumar, N. M., and Gilula, N. B. (1996). The gap junction communication channel.
Cell 84, 381–388. doi: 10.1016/S0092-8674(00)81282-9
Kwon, T., Harris, A. L., Rossi, A., and Bargiello, T. A. (2011). Molecular
dynamics simulations of the Cx26 hemichannel: evaluation of structural models
with Brownian dynamics. J. Gen. Physiol. 138, 475–493. doi: 10.1085/jgp.201
110679
Lee, J. R., Derosa, A. M., and White, T. W. (2009). Connexin mutations
causing skin disease and deafness increase hemichannel activity and cell death
when expresses in Xenopus oocytes. J. Invest. Dermatol. 129, 870–878. doi:
10.1038/jid.2008.335
Li, C., Meng, Q., Yu, X., Jing, X., Xu, P., and Luo, D. (2012). Regulatory eﬀect of
connexin 43 on basal Ca2+ signaling in rat ventricular myocytes. PLoS ONE
7:e36165. doi: 10.1371/journal.pone.0036165
Li, F., Sugishita, K., Su, Z., Ueda, I., and Barry, W. H. (2001). Activation
of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit
ventricular myocytes during metabolic inhibition. J. Mol. Cell Cardiol. 33,
2145–2155. doi: 10.1006/jmcc.2001.1477
Li, X., Zhao, H., Tan, X., Kostrzewa, R. M., Du, G., Chen, Y., et al. (2015). Inhibition
of connexin43 improves functional recovery after ischemic brain injury in
neonatal rats. Glia doi: 10.1002/glia.22826 [Epub ahead of print].
Liang, G. S., de Miguel, M., Gómez-Hernández, J. M., Glass, J. D., Scherer,
S. S., Mintz, M., et al. (2005). Severe neuropathy with leaky connexin32
hemichannels. Ann. Neurol. 57, 749–754. doi: 10.1002/ana.20459
Lopez, W., Gonzalez, J., Liu, Y., Harris, A. L., and Contreras, J. E. (2013). Insights
on the mechanisms of Ca(2+) regulation of connexin26 hemichannels revealed
by human pathogenic mutations (D50N/Y). J. Gen. Physiol. 142, 23–35. doi:
10.1085/jgp.201210893
Lu, D., Soleymani, S., Madakshire, R., and Insel, P. A. (2012). ATP released
from cardiac ﬁbroblasts via connexin hemichannels activates proﬁbrotic P2Y2
receptors. FASEB J. 26, 2580–2591. doi: 10.1096/fj.12–204677
Maeda, S., Nakagawa, S., Suga, M., Yamashita, E., Oshima, A., Fujiyoshi, Y., et al.
(2009). Structure of the connexin 26 gap junction channel at 3.5 A resolution.
Nature 458, 597–602. doi: 10.1038/nature07869
Mandal, A., Shahidullah, M., and Delamere, N. A. (2015). Calcium entry via
connexin hemichannels in lens epithelium. Exp. Eye Res. 132C, 52–58. doi:
10.1016/j.exer.2015.01.012
Martínez, A. D., Acuña, R., Figueroa, V., Maripillan, J., and Nicholson, B. (2009).
Gap-junction channels dysfunction in deafness and hearing loss. Antioxid.
Redox. Signal. 11, 309–322. doi: 10.1089/ars.2008.2138
Martinez, A. D., Hayrapetyan, V., Moreno, A. P., and Beyer, E. C. (2002).
Connexin43 and connexin45 form heteromeric gap junction channels in which
individual components determine permeability and regulation. Circ. Res. 90,
1100–1107. doi: 10.1161/01.RES.0000019580.64013.31
McClain, J. L., Grubišic´, V., Fried, D., Gomez-Suarez, R. A., Leinninger,
G. M., Sévigny, J., et al. (2014). Ca2+ responses in enteric glia are
mediated by connexin-43 hemichannels and modulate colonic transit in mice.
Gastroenterology 146, 497–507.e1. doi: 10.1053/j.gastro.2013.10.061
Meigh, L., Hussain, N., Mulkey, D. K., and Dale, N. (2014). Connexin26
hemichannels with a mutation that causes KID syndrome in humans
lacksensitivity to CO2. Elife 3:e04249. doi: 10.7554/eLife.04249
Mese, G., Sellitto, C., Li, L., Wang, H. Z., Valiunas, V., Richard, G., et al. (2011).
The Cx26-G45E mutation displays increased hemichannel activity in a mouse
model of the lethal form of keratitis-ichthyosis-deafness syndrome. Mol. Biol.
Cell 22, 4776–4786. doi: 10.1091/mbc.E11-09-0778
Mhaske, P. V., Levit, N. A., Li, L., Wang, H. Z., Lee, J. R., Shuja, Z., et al. (2013). The
human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-
deafness syndrome display increased hemichannel activity. Am. J. Physiol. Cell
Physiol. 304, C1150–C1158. doi: 10.1152/ajpcell.00374.2012
Minogue, P. J., Tong, J. J., Arora, A., Russell-Eggitt, I., Hunt, D. M., Moore, A. T.,
et al. (2009). A mutant connexin50 with enhanced hemichannel function leads
to cell death. Invest. Ophthalmol. Vis. Sci. 50, 5837–5845. doi: 10.1167/iovs.09-
3759
Mylvaganam, S., Ramani, M., Krawczyk, M., and Carlen, P. L. (2014). Roles of
gap junctions, connexins, and pannexins in epilepsy. Front. Physiol. 5:172. doi:
10.3389/fphys.2014.00172
Nelson, M. T., French, R. J., and Krueger, B. K. (1984). Voltage-dependent calcium
channels from brain incorporated into planar lipid bilayers. Nature 308, 77–80.
doi: 10.1038/308077a0
Nualart-Marti, A., del Molino, E. M., Grandes, X., Bahima, L., Martin-Satué,
M., Puchal, R., et al. (2013). Role of connexin 32 hemichannels in the
release of ATP from peripheral nerves. Glia 61, 1976–1989. doi: 10.1002/glia.
22568
O’Carroll, S. J., Alkadhi, M., Nicholson, L. F., and Green, C. R. (2008).
Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal
cell death after spinal cord injury. Cell Commun. Adhes. 15, 27–42. doi:
10.1080/15419060802014164
Oh, S., Ri, Y., Bennett, M. V., Trexler, E. B., Verselis, V. K., and Bargiello,
T. A. (1997). Changes in permeability caused by connexin 32 mutations
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 July 2015 | Volume 9 | Article 267
Retamal et al. Leaky hemichannels
underlie X-linked Charcot-Marie-Tooth disease. Neuron 19, 927–938. doi:
10.1016/S0896-6273(00)80973-3
Orellana, J. A., Froger, N., Ezan, P., Jiang, J. X., Bennett, M. V., Naus, C. C., et al.
(2011a). ATP and glutamate released via astroglial connexin 43 hemichannels
mediate neuronal death through activation of pannexin 1 hemichannels.
J. Neurochem. 118, 826–840. doi: 10.1111/j.1471-4159.2011.07210
Orellana, J. A., Shoji, K. F., Abudara, V., Ezan, P., Amigou, E., Saez, P. J., et al.
(2011b). Amyloid β-induced death in neurons involves glial and neuronal
hemichannels. J. Neurosci. 31, 4962–4977. doi: 10.1523/JNEUROSCI.6417-
10.2011
Orellana, J. A., Saez, J. C., Bennett, M. V., Berman, J.W., Morgello, S., and Eugenin,
E. A. (2014). HIV increases the release of dickkopf-1 protein from human
astrocytes by a Cx43 hemichannel-dependent mechanism. J. Neurochem. 128,
752–763. doi: 10.1111/jnc.12492
Orellana, J. A., von Bernhardi, R., Giaume, C., and Sáez, J. C. (2012). Glial
hemichannels and their involvement in aging and neurodegenerative diseases.
Rev. Neurosci. 23, 163–177. doi: 10.1515/revneuro-2011-0065
Patel, D., Gemel, J., Xu, Q., Simon, A. R., Lin, X., Matiukas, A., et al. (2014).
Atrial ﬁbrillation-associated connexin40 mutants make hemichannels and
synergistically form gap junction channels with novel properties. FEBS Lett.
588, 1458–1464. doi: 10.1016/j.febslet.2014.01.010
Paul, D. L., Ebihara, L., Takemoto, L. J., Swenson, K. I., and Goodenough, D. A.
(1991). Connexin46, a novel lens gap junction protein, induces voltage-gated
currents in nonjunctional plasma membrane of Xenopus oocytes. J. Cell Biol.
115, 1077–1089. doi: 10.1083/jcb.115.4.1077
Payton, B.W., Bennett, M. V., and Pappas, G. D. (1969). Permeability and structure
of junctional membranes at an electrotonic synapse. Science 166, 1641–1643.
doi: 10.1126/science.166.3913.1641
Plotkin, L. I. (2014). Connexin 43 hemichannels and intracellular signaling in bone
cells. Front. Physiol. 5:131. doi: 10.3389/fphys.2014.00131
Ponsaerts, R., De Vuyst, E., Retamal, M., D’hondt, C., Vermeire, D., Wang, N.,
et al. (2010). Intramolecular loop/tail interactions are essential for connexin
43-hemichannel activity. FASEB J. 24, 4378–4395. doi: 10.1096/fj.09-153007
Ponsaerts, R., Wang, N., Himpens, B., Leybaert, L., and Bultynck, G. (2012). The
contractile system as a negative regulator of the connexin43 hemichannel. Biol.
Cell 104, 367–377. doi: 10.1111/boc.201100079
Rackauskas, M., Neverauskas, V., and Skeberdis, V. A. (2010). Diversity and
properties of connexin gap junction channels.Medicina (Kaunas) 46, 1–12.
Rana, S., and Dringen, R. (2007). Gap junction hemichannel-mediated release
of glutathione from cultured rat astrocytes. Neurosci. Lett. 415, 45–48. doi:
10.1016/j.neulet.2006.12.043
Ren, Q., Riquelme, M. A., Xu, J., Yan, X., Nicholson, B. J., Gu, S., et al. (2013).
Cataract-causing mutation of human connexin 46 impairs gap junction, but
increases hemichannel function and cell death. PLoS ONE 8:e74732. doi:
10.1371/journal.pone.0074732
Retamal, M. A., Alcayaga, J., Verdugo, C. A., Bultynck, G., Leybaert, L., Sáez, P. J.,
et al. (2014a). Opening of pannexin- and connexin-based channels increases the
excitability of nodose ganglion sensory neurons. Front. Cell Neurosci. 8:158. doi:
10.3389/fncel.2014.00158
Retamal, M. A., Reyes, E. P., and Alcayaga, J. (2014b). Petrosal ganglion:
a more complex role than originally imagined. Front. Physiol. 5:474. doi:
10.3389/fphys.2014.00474
Retamal, M. A., Cortés, C. J., Reuss, L., Bennett, M. V., and Sáez, J. C.
(2006). S-nitrosylation and permeation through connexin 43 hemichannels in
astrocytes: induction by oxidant stress and reversal by reducing agents. Proc.
Natl. Acad. Sci. U.S.A. 103, 4475–4480. doi: 10.1073/pnas.0511118103
Retamal, M. A., Froger, N., Palacios-Prado, N., Ezan, P., Sáez, P. J., and Sáez,
J. C., et al. (2007). Cx43 hemichannels and gap junction channels in astrocytes
are regulated oppositely by proinﬂammatory cytokines released from activated
microglia. J. Neurosci. 27, 13781–13792. doi: 10.1523/JNEUROSCI.2042-
07.2007
Rovegno, M., Soto, P. A., Sáez, P. J., Naus, C. C., Sáez, J. C., and von Bernhardi, R.
(2015). Connexin43 hemichannels mediate secondary cellular damage spread
from the trauma zone to distal zones in astrocyte monolayers. Glia 63,
1185–1199. doi: 10.1002/glia.22808
Rufer, M., Wirth, S. B., Hofer, A., Dermietzel, R., Pastor, A., Kettenmann, H.,
et al. (1996). Regulation of connexin-43, GFAP, and FGF-2 is not
accompanied by changes in astroglial coupling in MPTP-lesioned,
FGF-2-treated parkinsonian mice. J. Neurosci. Res. 46, 606–617. doi:
10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.0.CO;2-N
Sáez, J. C., Berthoud, V. M., Branes, M. C., Martinez, A. D., and Beyer, E. C.
(2003). Plasma membrane channels formed by connexins: their regulation and
functions. Physiol. Rev. 83, 1359–1400. doi: 10.1152/physrev.00007.2003
Sáez, J. C., and Leybaert, L. (2014). Hunting for connexin hemichannels. FEBS Lett.
588, 1205–1211. doi: 10.1016/j.febslet.2014.03.004
Sáez, J. C., Schalper, K. A., Retamal, M. A., Orellana, J. A., Shoji, K. F.,
and Bennett, M. V. (2010). Cell membrane permeabilization via connexin
hemichannels in living and dying cells. Exp. Cell Res. 316, 2377–2389. doi:
10.1016/j.yexcr.2010.05.026
Samoilova, M., Wentlandt, K., Adamchik, Y., Velumian, A. A., and Carlen, P. L.
(2008). Connexin 43mimetic peptides inhibit spontaneous epileptiform activity
in organotypic hippocampal slice cultures. Exp. Neurol. 210, 762–775. doi:
10.1016/j.expneurol.2008.01.005
Sanchez, H. A., Bienkowski, R., Slavi, N., Srinivas, M., and Verselis, V. K. (2014).
Altered inhibition of Cx26 hemichannels by pH and Zn2+ in the A40V
mutation associated with keratitis-ichthyosis-deafness syndrome. J. Biol. Chem.
289, 21519–21532. doi: 10.1074/jbc.M114.578757
Sánchez, H. A., Mese, G., Srinivas, M., White, T. W., and Verselis, V. K.
(2010). Diﬀerentially altered Ca2+ regulation and Ca2+ permeability in
Cx26 hemichannels formed by the A40V and G45E mutations that cause
keratitis ichthyosis deafness syndrome. J. Gen. Physiol. 136, 47–62. doi:
10.1085/jgp.201010433
Sanchez, H. A., Villone, K., Srinivas, M., and Verselis, V. K. (2013). The D50N
mutation and syndromic deafness: altered Cx26 hemichannel properties caused
by eﬀects on the pore and intersubunit interactions. J. Gen. Physiol. 142, 3–22.
doi: 10.1085/jgp.201310962
Schalper, K. A., Palacios-Prado, N., Orellana, J. A., and Sáez, J. C. (2008). Currently
used methods for identiﬁcation and characterization of hemichannels. Cell
Commun. Adhes. 15, 207–218. doi: 10.1080/15419060802014198
Schalper, K. A., Sánchez, H. A., Lee, S. C., Altenberg, G. A., Nathanson, M. H., and
Sáez, J. C. (2010). Connexin 43 hemichannels mediate the Ca2+ inﬂux induced
by extracellular alkalinization. Am. J. Physiol. Cell Physiol. 299, C1504–C1515.
doi: 10.1152/ajpcell.00015.2010
Schock, S. C., Leblanc, D., and Hakim, A. M., and Thompson, C. S. (2008).
ATP release by way of connexin 36 hemichannels mediates ischemic
tolerance in vitro. Biochem. Biophys. Res. Commun. 368, 138–144. doi:
10.1016/j.bbrc.2008.01.054
Scott, C. A., Tattersall, D., O’Toole, E. A., and Kelsell, D. P. (2012). Connexins
in epidermal homeostasis and skin disease. Biochim. Biophys. Acta 1818,
1952–1961. doi: 10.1016/j.bbamem.2011.09.004
Shintani-Ishida, K., Uemura, K., and Yoshida, K. (2007). Hemichannels in
cardiomyocytes open transiently during ischemia and contribute to reperfusion
injury following brief ischemia. Am. J. Physiol. Heart Circ. Physiol. 293, H1714–
H1720. doi: 10.1152/ajpheart.00022.2007
Sipos, A., Vargas, S. L., Toma, I., Hanner, F., Willecke, K., and Peti-Peterdi, J.
(2009). Connexin 30 deﬁciency impairs renal tubular ATP release and pressure
natriuresis. J. Am. Soc. Nephrol. 20, 1724–1732. doi: 10.1681/ASN.2008101099
Söhl, G., Eiberger, J., Jung, Y. T., Kozak, C. A., and Willecke, K. (2001). The mouse
gap junction gene connexin29 is highly expressed in sciatic nerve and regulated
during brain development.Biol. Chem. 382, 973–978. doi: 10.1515/BC.2001.122
Söhl, G., and Willecke, K. (2004). Gap junctions and the connexin protein family.
Cardiovasc. Res. 62, 228–232. doi: 10.1016/j.cardiores.2003.11.013
Stehberg, J., Moraga-Amaro, R., Salazar, C., Becerra, A., Echeverría, C., Orellana,
J. A., et al. (2012). Release of gliotransmitters through astroglial connexin 43
hemichannels is necessary for fear memory consolidation in the basolateral
amygdala. FASEB J. 26, 3649–3657. doi: 10.1096/fj.11-198416
Stong, B. C., Chang, Q., Ahmad, S., and Lin, X. (2006). A novel mechanism
for connexin 26 mutation linked deafness: cell death caused by
leaky gap junction hemichannels. Laryngoscope 116, 2205–2210. doi:
10.1097/01.mlg.0000241944.77192.d2
Stout, C. E., Costantin, J. L., Naus, C. C., and Charles, A. C. (2002). Intercellular
calcium signaling in astrocytes via ATP release through connexin hemichannels.
J. Biol. Chem. 277, 10482–10488. doi: 10.1074/jbc.M109902200
Sun, Y., Hills, M. D., Ye, W. G., Tong, X., and Bai, D. (2014). Atrial ﬁbrillation-
linked germline GJA5/connexin40 mutants showed an increased hemichannel
function. PLoS ONE 9:e95125. doi: 10.1371/journal.pone.0095125
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 July 2015 | Volume 9 | Article 267
Retamal et al. Leaky hemichannels
Svenningsen, P., Burford, J. L., and Peti-Peterdi, J. (2013). ATP releasing connexin
30 hemichannels mediate ﬂow-induced calcium signaling in the collecting duct.
Front. Physiol. 4:292. doi: 10.3389/fphys.2013.00292
Takada, H., Furuya, K., and Sokabe, M. (2014). Mechanosensitive ATP release
from hemichannels and Ca2+ inﬂux through TRPC6 acceleratewound closure
in keratinocytes. J. Cell Sci. 127(Pt 19), 4159–4171. doi: 10.1242/jcs.147314
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., et al. (2006).
Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from
hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281,
21362–21368. doi: 10.1074/jbc.M600504200
Takeuchi, H., Mizoguchi, H., Doi, Y., Jin, S., Noda, M., Liang, J., et al. (2011).
Blockade of gap junction hemichannel suppresses disease progression in mouse
models of amyotrophic lateral sclerosis and Alzheimer’s disease. PLoS ONE
6:e21108. doi: 10.1371/journal.pone.0021108
Takeuchi, H., and Suzumura, A. (2014). Gap junctions and hemichannels
composed of connexins: potential therapeutic targets for neurodegenerative
diseases. Front. Cell Neurosci. 8:189. doi: 10.3389/fncel.2014.00189
Tong, J. J., Minogue, P. J., Guo, W., Chen, T. L., Beyer, E. C., Berthoud, V. M., et al.
(2011). Diﬀerent consequences of cataract-associated mutations at adjacent
positions in the ﬁrst extracellular boundary of connexin50. Am. J. Physiol. Cell
Physiol. 300, C1055–C1064. doi: 10.1152/ajpcell.00384.2010
Vinken, M., Vanhaecke, T., Papeleu, P., Snykers, S., Henkens, T., and Rogiers, V.
(2006). Connexins and their channels in cell growth and cell death. Cell. Signal.
18, 592–600. doi: 10.1016/j.cellsig.2005.08.012
Wang, H., Cao, X., Lin, Z., Lee, M., Jia, X., Ren, Y., et al. (2015). Exome sequencing
reveals mutation in GJA1 as a cause of keratoderma-hypotrichosis-leukonychia
totalis syndrome. Hum. Mol. Genet. 24, 243–250. doi: 10.1093/hmg/
ddu442
Wang, N., De Bock, M., Decrock, E., Bol, M., Gadicherla, A., Vinken, M.,
et al. (2013a). Paracrine signaling through plasma membrane hemichannels.
Biochim. Biophys. Acta 1828, 35–50. doi: 10.1016/j.bbamem.2012.07.002
Wang, Y. F., Munemasa, S., Nishimura, N., Ren, H. M., Robert, N., Han, M., et al.
(2013b). Identiﬁcation of cyclic GMP-activated nonselective Ca2+-permeable
cation channels and associated CNGC5 and CNGC6 genes in Arabidopsis guard
cells. Plant Physiol. 163, 578–590. doi: 10.1104/pp.113.225045
Wang, X., Ramirez, A., and Budunova, I. (2009). Overexpression of connexin26
in the basal keratinocytes reduces sensitivity to tumor promoter TPA. Exp.
Dermatol. 19, 633–640. doi: 10.1111/j.1600-0625.2009.01013.x
Wong, C. W., Christen, T., Roth, I., Chadjichristos, C. E., Derouette, J. P.,
Foglia, B. F., et al. (2006). Connexin37 protects against atherosclerosis
by regulating monocyte adhesion. Nat. Med. 12, 950–954. doi: 10.1038/
nm1441
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H.,
Gutmann, D. H., et al. (2008). Astrocytes as determinants of disease progression
in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251–253. doi:
10.1038/nn2047
Yao, K., Wang, W., Zhu, Y., Jin, C., Shentu, X., Jiang, J., et al. (2011).
A novel GJA3 mutation associated with congenital nuclear pulverulent and
posterior polar cataract in a Chinese family. Hum. Mutat. 32, 1367–1370. doi:
10.1002/humu.21552
Ye, Z. C., Wyeth, M. S., Baltan-Tekkok, S., and Ransom, B. R. (2003). Functional
hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci.
23, 3588–3596.
Yoon, J. J., Green, C. R., O’Carroll, S. J., and Nicholson, L. F. (2010).
Dose-dependent protective eﬀect of connexin43 mimetic peptide against
neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res. 92,
153–162. doi: 10.1016/j.eplepsyres.2010.08.014
Zhang, Y., and Hao, H. (2013). Conserved glycine at position 45 of major cochlear
connexins constitutes a vital component of the Ca2+ sensor for gating of gap
junction hemichannels. Biochem. Biophys. Res. Commun. 436, 424–429. doi:
10.1016/j.bbrc.2013.05.118
Zhao, P. Y., Gan, G., Peng, S., Wang, S. B., Chen, B., Adelman, R. A., et al. (2015).
TRP channels localize to subdomains of the apical plasma membrane in human
fetal retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 56, 1916–1923.
doi: 10.1167/iovs.14-15738
Zhu, Y., Yu, H., Wang, W., Gong, X., and Yao, K. (2014). A novel GJA8
mutation (p.V44A) causing autosomal dominant congenital cataract. PLoS
ONE 9:e115406. doi: 10.1371/journal.pone.0115406
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2015 Retamal, Reyes, García, Pinto, Martínez and González. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 July 2015 | Volume 9 | Article 267
